You are here:

NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Mifamurtide for the treatment of osteosarcoma

Technology appraisal guidance
Reference number: TA235
Published: 26 October 2011

Guidance
Tools and resources
Information for the public
History

Appendix A: matrix of stakeholders

Appendix A: matrix of stakeholders

Appendix A: matrix of stakeholders
11 November 2013
(96 Kb 27 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 06 November 2013